Shares of Allscripts (MDRX) , a provider of practice management and electronic health record technology to various healthcare professions, were climbing over 2% during early Tuesday morning trading following an upgrade of the stock at Cantor Fitzgerald.

The firm raised its rating on the stock to "Overweight" from "Neutral" and hiked its price target to $17 from $15.

Allscripts's acquisition of McKesson's (MCK) Enterprise Information Solutions health IT business for $185 million in cash earlier this month will fill some product gaps and generate material cost saving opportunities for the firm, Cantor analyst Steven Halper. He also sees an improved risk/reward offering.

More of What's Trending on TheStreet:

More from Stocks

Dow Jumps, Stocks Rise on Signs of a Thaw in U.S. and China Trade Battle

Dow Jumps, Stocks Rise on Signs of a Thaw in U.S. and China Trade Battle

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

Synchrony, Exelixis Look Like Good Values

Synchrony, Exelixis Look Like Good Values

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

Tilray Shares Are Going Absolutely Haywire -- Here's Why

Tilray Shares Are Going Absolutely Haywire -- Here's Why